Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2006 (Vol. 26, No. 4)


  • A way to fight spam
  • Ethically questionable
Every now and then I find a site, which has such a wide audience and addresses a broad Internet-related concern that I feel compelled to write about it, even though it doesn't directly deal with biotechnology. The issue I'm talking about is the need to register at sites. I've complained about this on numerous occasions because of the tendency of some sites to sell that information, ultimately generating spam to visitors. Yes, I realize there are other reasons for registration and other uses of the information, but spam is a common problem. One approach to combating the spam issue is taken by BugMeNot.com, which provides fake login information for many sites requiring registration. While I don't necessarily condone fighting one evil (misuse of registration) with another (deception), I confess that I did try it just to see if it worked. Sure enough, I could log in to a site with the fake info provided. Is this ethical and a fair way to fight spam? I won't touch that one. You decide.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »